← Back
$ACAD All transactions

ACADIA PHARMACEUTICALS INC

▼ SELL 10b5-1 Plan

$ Value

$554K

Shares

22,000

Price

$25

Filed

Aug 19

Insider

Name

Schneyer Mark C.

Title

EVP, CHIEF FINANCIAL OFFICER

CIK

0001899977

Roles

Officer

Transaction Details

Transaction Date

2025-08-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

40,130

Footnotes

The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Filing Info

Accession No.

0001415889-25-022359

Form Type

4

Issuer CIK

0001070494

Schneyer Mark C.'s History

Date Ticker Type Value
2026-04-07 ACAD $60K
2026-04-05 ACAD M
2026-04-05 ACAD M $0
2026-03-26 ACAD $69K
2026-03-26 ACAD $804
2026-03-25 ACAD $90K
2026-03-25 ACAD M
2026-03-25 ACAD M $0
2026-03-24 ACAD M
2026-03-24 ACAD M $0

Other Insiders at ACAD (90d)

Insider Bought Sold Last
Rhodes Jennifer J
EVP, CHIEF LEGAL OFFICER, SEC
$83K 2026-03-25
Kihara James
PRINCIPAL ACCOUNTING OFFICER
$65K 2026-04-07
Owen Adams Catherine
Chief Executive Officer
$250K 2026-03-25
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
$74K 2026-03-25
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
$219K 2026-04-07